Oncolytics Biotech, Inc. (ONCY) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-14
3:05 pm
Sale
2025-09-3013GOncolytics Biotech Inc.
ONCY
Anson Funds Management LP7,649,050
7.000%
-536,693decrease
(-6.56%)
Filing
History
2025-02-14
6:30 pm
Purchase
2024-12-3113GOncolytics Biotech Inc.
ONCY
Anson Funds Management LP8,185,743
9.600%
8,185,743increase
(New Position)
Filing
History